FairValu
INTUITIVE SURGICAL INC

INTUITIVE SURGICAL INC

ISRGNasdaqGS
Medical Instruments & Supplies • Healthcareintuitive.com
Current Price
$369.150.00%
Market Cap
$132.26B
Shares Outstanding: 358.28M
Volume
-
Avg Vol (3M): -
Next Earnings
-
52 Week Range
Low: $--High: $--

Comprehensive AI Analysis

Strategic AI Analysis for ISRG

Checking whether the approved providers contain enough current financial data for a reliable report.

Summary

Source-linked company research for ISRG

Checking Factor Scorecard coverage

Financial statement coverage is being verified before factor scores are shown.

Price Chart

NASDAQ:ISRG via TradingView

Loading TradingView chart...

Overview

Quarterly income statement data isn't available for this company.

No Data

No annual financial data available.

Financial Fundamentals

Growth, quality, valuation, cash generation, and balance-sheet strength.

Sector: Healthcare

Growth

TTM revenue plus current, long-term, forward, and accelerating top-line trends.

Revenue
-
Revenue Growth
20.7%
Strong
Revenue CAGR 3Y
-
Forward Revenue Growth
16.7%
Strong
Revenue Acceleration
-0.1%
Slowing

Earnings

Trailing EPS, current EPS growth, long-term compounding, surprise, and forward expectations.

EPS (TTM)
8.87
Profitable
EPS Growth
20.4%
Strong
EPS CAGR 3Y
-
EPS Surprise
11.9%
Strong Beat
Forward EPS
10.78
Profitable
Fwd Revenue Growth
16.7%
Forward EPS Growth
12.0%
Moderate

Profitability

TTM margin and return metrics that reflect pricing power and business quality.

Gross Margin
66.7%
High
Operating Margin
31.3%
High
Net Margin
28.4%
High
Margin vs Trend
-
ROE
17.3%
Excellent
ROIC
18.6%
Strong

Cash Flow

TTM free cash flow, growth, margin, and operating-cash conversion quality.

Free Cash Flow
$3.22B
Positive
FCF Growth
61.6%
Excellent
FCF Margin
-
Cash Conversion
1.18x
Strong

Valuation

Metrics ranked by issuer type, financial state, and input quality.

Growth companyPrimary lens

Forward P/E

Forward P/E is the primary lens because positive expected earnings make the next operating period directly assessable.

Forward P/EPrimary
34.25x
High
EV / EBITDASupporting
31.97x
High
EV / FCFSupporting
40.18x
High
Trailing P/ESupporting
41.62x
High

Financial Health

Latest-quarter liquidity and leverage checks plus TTM interest coverage.

Current Ratio
4.96x
Healthy
Quick Ratio
3.58x
Healthy
Debt / Equity
-
Interest Coverage
-

Shareholder Signals

Capital returns and dilution checks sourced from statements and insider filings.

Buyback Yield
2.7%
Positive
Net Insider Buys
-15
Selling

Peer Comparison

TickerPrice
ISRGINTUITIVE SURGICAL INC
$369.15
Company Profile

About the Company

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Next Earnings Date

Oct 20, 2026

Loading latest news...

Revenue segmentation

Loading segment disclosures…